Advertisement
Screener

Apogee Therapeutics, Inc. (APGE) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

Apogee Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period

Apogee Therapeutics, Inc. (APGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 163.26 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-10

  • Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 138.19K shares, a 345.16% increase year-over-year.
  • Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 25.08K shares, a 45.68% decline year-over-year.
  • Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 47.08K shares, a 168032.14% increase year-over-year.
  • Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 134.73K shares, a 751.49% increase year-over-year.
  • Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 259.02K shares, a 654.89% increase from fiscal 2024.
  • Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 34.31K shares, a 169.94% increase from fiscal 2023.
  • Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 12.71K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month
2026-06-30138.19K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
163.26K shares
10-Q · filed 2026-08-10
210.34K shares
derived: sum of 3 quarters · filed 2026-08-10
345.07K shares
derived: sum of 4 quarters · filed 2026-08-10
2026-03-3125.08K shares
10-Q · filed 2026-05-11
72.15K shares
derived: sum of 2 quarters · filed 2026-05-11
206.88K shares
derived: sum of 3 quarters · filed 2026-05-11
237.93K shares
derived: sum of 4 quarters · filed 2026-05-11
2025-12-3147.08K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02
181.81K shares
derived: sum of 2 quarters · filed 2026-03-02
212.85K shares
derived: sum of 3 quarters · filed 2026-03-02
259.02K shares
10-K · filed 2026-03-02
2025-09-30134.73K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10
165.77K shares
derived: sum of 2 quarters · filed 2025-11-10
211.94K shares
10-Q · filed 2025-11-10
211.97K shares
derived: sum of 4 quarters · filed 2025-11-10
2025-06-3031.04K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
77.21K shares
10-Q · filed 2025-08-11
77.24K shares
derived: sum of 3 quarters · filed 2025-08-11
93.06K shares
derived: sum of 4 quarters · filed 2025-08-11
2025-03-3146.17K shares
10-Q · filed 2025-05-12
46.19K shares
derived: sum of 2 quarters · filed 2025-05-12
62.02K shares
derived: sum of 3 quarters · filed 2025-05-12
2024-12-3128.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
15.85K shares
derived: sum of 2 quarters · filed 2025-03-03
34.31K shares
10-K · filed 2025-03-03
2024-09-3015.82K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
34.28K shares
10-Q · filed 2024-11-12
2024-06-3018.46K shares
10-Q · filed 2024-08-12
2023-12-3112.71K shares
10-K · filed 2024-03-05